Schedule 13G ownership disclosure

Monopar Therapeutics Inc

Security class unavailable · CUSIP: 61023L207

Event date: 2024-10-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
562,482
Percent of class
10.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001274173-24-000084
Form type
SC 13G
Filer
Janus Henderson Group Ltd.
CIK
CIK 1274173
Filed
Nov 06, 2024
Reporting period
Oct 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub